HF
IGC icon

HRT Financial’s IGC Pharma IGC Stock Holding History

HRT Financial’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-60,258
Closed -$25K – 3558
2025
Q3 		$25K Buy
+60,258
New +$22.9K ﹤0.01% 2681
2025
Q1 		– Sell
-27,737
Closed -$9K – 2905
2024
Q4 		$9K Buy
+27,737
New +$10.4K ﹤0.01% 2291
2023
Q4 		– Sell
-18,148
Closed -$6K – 2668
2023
Q3 		$6K Buy
+18,148
New +$6.49K ﹤0.01% 2167
2022
Q3 		– Sell
-19,694
Closed -$10K – 3123
2022
Q2 		$10K Buy
+19,694
New +$12.4K ﹤0.01% 2681
2021
Q4 		– Sell
-12,749
Closed -$18K – 3588
2021
Q3 		$18K Buy
+12,749
New +$20.6K ﹤0.01% 3151

Other funds holding IGC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM

HRT Financial's IGC Position: Q4 2025 in Review

HRT Financial sold out of IGC Pharma (IGC) in Q4 2025, closing a stake of 60,258 shares — an estimated $25K sold.

HRT Financial first reported a position in IGC in Q3 2021 and held it in 5 quarters. The position peaked at $25K in Q3 2025. 30 funds tracked by Wall St. Rank hold IGC as of Q4 2025.

  • HRT Financial reported no remaining IGC Pharma position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 60,258 IGC Pharma shares in Q4 2025, an estimated $25K.
  • HRT Financial first reported a position in IGC Pharma in Q3 2021 and held it in 5 quarters.
  • HRT Financial's IGC Pharma position peaked at $25K in Q3 2025.
  • 30 funds tracked by Wall St. Rank held IGC Pharma as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.